Aytu BioPharma, Inc. ( AYTU) - Stock Earnings
AYTU Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
AYTU Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -10.6 million USD | 15.2 million USD |
| 2026Q1 | -5.6 million USD | 12.4 million USD |
| 2026Q2 | -15000 USD | 16.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AYTU Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -15.8 million USD | 65.2 million USD |
| 2025 | -13.6 million USD | 66.4 million USD |
| 2026 | -14.3 million USD | 57.6 million USD |
| 2026 Est. | — | — |
AYTU
Price: $1.97
Earnings Per Share: -1.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 55600
Ebitda: -9.2 millionMarket Capitalization: 22.2 million